Early ultra-high-dose methylcobalamin treatment prolongs survival in amyotrophic lateral sclerosis patients

Authors :: Shigeki Kuzuhara
Ryuji Kaji
T. Imai
Yasuo Ohashi
Kunio Tashiro
Koichi Okamoto
Takao Takase
Yasuo Iwasaki
Masanori Nakagawa
Hiroki Shimizu
Source :: Journal of the Neurological Sciences. 357:e428
Publication Year :: 2015
Publisher :: Elsevier BV, 2015.

Subjects :: medicine.medical_specialty
Neurology
business.industry
Internal medicine
Methylcobalamin
Medicine
Neurology (clinical)
Amyotrophic lateral sclerosis
business
medicine.disease
Gastroenterology
medicine.drug

Tools